![Kirk Andriano](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kirk Andriano
Directeur Technique/Scientifique/R&D chez CURATIVE BIOSCIENCES, INC.
Profil
Kirk Andriano is currently the Director at BBS-Bioactive Bone Substitutes Plc and the Chief Scientific Officer at Curative Biosciences, Inc. He previously held positions as the Director & Vice President-Research & Development at Elute, Inc., the Executive Director-Preclinical Development at MacroMed, Inc., the Executive Director-Research & Development at Medicus Biosciences LLC, the Vice President-Research & Development at Histogenics Corp., the Vice President-Research & Development at Inion Oy, and the Chief Technology Officer at ProChon Biotech Ltd.
Postes actifs de Kirk Andriano
Sociétés | Poste | Début |
---|---|---|
BBS-BIOACTIVE BONE SUBSTITUTES OYJ | Directeur/Membre du Conseil | - |
CURATIVE BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 01/01/2008 |
Anciens postes connus de Kirk Andriano
Sociétés | Poste | Fin |
---|---|---|
Medicus Biosciences LLC
![]() Medicus Biosciences LLC BiotechnologyHealth Technology Medicus Biosciences LLC is an American company that manufactures biological products. | Directeur Technique/Scientifique/R&D | 02/01/2019 |
ProChon Biotech Ltd.
![]() ProChon Biotech Ltd. Pharmaceuticals: MajorHealth Technology ProChon Biotech, Ltd. manufactures innovative growth factor-based therapies in regenerative medicine and orthopedics. The company was founded by Avner Yayon in 1995 and is headquartered in Tel Aviv, Israel. | Directeur Technique/Scientifique/R&D | 02/01/2011 |
Inion Oy
![]() Inion Oy BiotechnologyHealth Technology Inion Oy is a medical devices company focused on the development and commercialization of innovative biodegradable and bioactive implants for applications in Spine and Specialty Orthopedics applications. By targeting key strategic markets in the USA and select territories in the rest of the world, Inion has built a product portfolio sold through a dedicated network of specialist distributors. Inion's products include biodegradable plates, screws, pins and membranes, which are used to enhance the healing of bone or soft tissue injuries, such as those caused by trauma or by reconstructive surgery. Inion's core expertise is in the design and manufacture of implants from its proprietary Inion Optima™ family of biomaterials, which enables the Company to develop medical implants with properties tailored for specific surgical applications, in terms of strength, flexibility and rate of degradation. Incorporated in 2000, Inion has offices in the UK and USA, and its head office, R&D and manufacturing facilities are in Tampere, Finland. | Directeur Technique/Scientifique/R&D | 02/01/2008 |
MacroMed, Inc.
![]() MacroMed, Inc. Pharmaceuticals: MajorHealth Technology Part of Boston Scientific Corp., MacroMed, Inc. develops and manufactures pharmaceutical products. The company is based in West Valley City, UT. The company was founded by Sung Wan Kim. The CEO is Thomas Bergmann. MacroMed was acquired by Protherics Plc on January 04, 2007 for $25 million. | Corporate Officer/Principal | 02/01/2003 |
Elute, Inc.
![]() Elute, Inc. Medical SpecialtiesHealth Technology Elute, Inc. develops polymer controlled drug delivery devices designed to prevent and treat orthopedic and other surgical bone infections. The company was founded by David W. Grainger and Dennis B. Farrar in 2010 and is headquartered in Salt Lake City, UT. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
BBS-BIOACTIVE BONE SUBSTITUTES OYJ | Health Technology |
CURATIVE BIOSCIENCES, INC. | Health Technology |
Entreprise privées | 6 |
---|---|
Histogenics Corp.
![]() Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
Elute, Inc.
![]() Elute, Inc. Medical SpecialtiesHealth Technology Elute, Inc. develops polymer controlled drug delivery devices designed to prevent and treat orthopedic and other surgical bone infections. The company was founded by David W. Grainger and Dennis B. Farrar in 2010 and is headquartered in Salt Lake City, UT. | Health Technology |
Inion Oy
![]() Inion Oy BiotechnologyHealth Technology Inion Oy is a medical devices company focused on the development and commercialization of innovative biodegradable and bioactive implants for applications in Spine and Specialty Orthopedics applications. By targeting key strategic markets in the USA and select territories in the rest of the world, Inion has built a product portfolio sold through a dedicated network of specialist distributors. Inion's products include biodegradable plates, screws, pins and membranes, which are used to enhance the healing of bone or soft tissue injuries, such as those caused by trauma or by reconstructive surgery. Inion's core expertise is in the design and manufacture of implants from its proprietary Inion Optima™ family of biomaterials, which enables the Company to develop medical implants with properties tailored for specific surgical applications, in terms of strength, flexibility and rate of degradation. Incorporated in 2000, Inion has offices in the UK and USA, and its head office, R&D and manufacturing facilities are in Tampere, Finland. | Health Technology |
MacroMed, Inc.
![]() MacroMed, Inc. Pharmaceuticals: MajorHealth Technology Part of Boston Scientific Corp., MacroMed, Inc. develops and manufactures pharmaceutical products. The company is based in West Valley City, UT. The company was founded by Sung Wan Kim. The CEO is Thomas Bergmann. MacroMed was acquired by Protherics Plc on January 04, 2007 for $25 million. | Health Technology |
Medicus Biosciences LLC
![]() Medicus Biosciences LLC BiotechnologyHealth Technology Medicus Biosciences LLC is an American company that manufactures biological products. | Health Technology |
ProChon Biotech Ltd.
![]() ProChon Biotech Ltd. Pharmaceuticals: MajorHealth Technology ProChon Biotech, Ltd. manufactures innovative growth factor-based therapies in regenerative medicine and orthopedics. The company was founded by Avner Yayon in 1995 and is headquartered in Tel Aviv, Israel. | Health Technology |